US 6620802
Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist
expired A61KA61K31/00A61K31/56
Quick answer
US patent 6620802 (Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist) held by Corcept Therapeutics Incorporated expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/00, A61K31/56, A61K31/567, A61K31/568